Literature DB >> 8762727

Serum concentrations of free and total insulin-like growth factor-I, IGF binding proteins -1 and -3 and IGFBP-3 protease activity in boys with normal or precocious puberty.

A Juul1, A Flyvbjerg, J Frystyk, J Müller, N E Skakkebaek.   

Abstract

OBJECTIVE: Circulating IGF-I and IGF binding protein-3 (IGFBP-3) levels both increase in puberty where growth velocity is high. The amount of free IGF-I is dependent on the IGF-I level and on the concentrations of the specific IGFBPs. Furthermore, IGFBP-3 proteolysis regulates the bioavailability of IGF-I. However, the concentration of free IGF-I and possible IGFBP-3 proteolytic activity in puberty has not previously been studied. SUBJECTS AND MEASUREMENTS: We investigated serum levels of easily dissociable IGF-I concentrations and ultrafiltrated free IGF-I levels by specific assays in 60 healthy boys and in 5 boys with precocious puberty before and during GnRH agonist treatment. In addition, total serum IGF-I, IGFBP-1 and IGFBP-3 levels as well as IGFBP-3 protease activity were determined.
RESULTS: Free (dissociable and ultrafiltrated) IGF-I concentrations were significantly higher in pubertal boys than in prepubertal children and correlated significantly with the molar ratio between IGF-I and IGFBP-3 (r = 0.69, P < 0.0001 and r = 0.54, P = 0.0008, respectively) and inversely with IGFBP-1 (r = -0.47, P < 0.0001 and r = -0.43, P = 0.0003, respectively). Multiple regression analysis suggested that IGFBP-3 level, and not IGFBP-1, was the major determinant of the free IGF-I serum level in normal boys. Free IGF-I levels were elevated in boys with precocious puberty and decreased during GnRH treatment. IGFBP-3 proteolysis was constant throughout puberty (mean 20%).
CONCLUSIONS: We conclude that easily dissociable and ultrafiltrated free IGF-I serum levels are increased in boys with normal and precocious puberty and suggest that the increased free IGF-I serum concentration in puberty primarily reflects changes in total concentrations of IGF-I and IGFBPs secondary to increased GH secretion, but that it is not influenced by changes in IGFBP-3 proteolysis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8762727     DOI: 10.1046/j.1365-2265.1996.711531.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  10 in total

1.  Determining the normal range for IGF-I, IGFBP-3, and ALS: new reference data based on current internal standards.

Authors:  Diana-Alexandra Ertl; Andreas Gleiss; Susanne Sagmeister; Gabriele Haeusler
Journal:  Wien Med Wochenschr       Date:  2014-09-04

2.  Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden.

Authors:  R Palmqvist; G Hallmans; S Rinaldi; C Biessy; R Stenling; E Riboli; R Kaaks
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

3.  Preliminary efficacy of the anti-insulin-like growth factor type 1 receptor antibody figitumumab in patients with refractory Ewing sarcoma.

Authors:  Heribert Juergens; Najat C Daw; Birgit Geoerger; Stefano Ferrari; Milena Villarroel; Isabelle Aerts; Jeremy Whelan; Uta Dirksen; Mary L Hixon; Donghua Yin; Tao Wang; Stephanie Green; Luisa Paccagnella; Antonio Gualberto
Journal:  J Clin Oncol       Date:  2011-10-24       Impact factor: 44.544

4.  Validating pathophysiological models of aging using clinical electronic medical records.

Authors:  David P Chen; Alexander A Morgan; Atul J Butte
Journal:  J Biomed Inform       Date:  2009-12-01       Impact factor: 6.317

5.  Bioactive insulin-like growth factor-I in obesity.

Authors:  J Frystyk; D J Brick; A V Gerweck; A L Utz; K K Miller
Journal:  J Clin Endocrinol Metab       Date:  2009-05-26       Impact factor: 5.958

6.  Serum Levels of Free Insulin-Like Growth Factor (IGF)-I in Normal Children.

Authors:  Atsuko Nimura; Noriyuki Katsumata; Toshiaki Tanaka
Journal:  Clin Pediatr Endocrinol       Date:  2004-07-07

7.  Free Insulin-like Growth Factor (IGF)-I in Children with PWS.

Authors:  Layla Damen; Melitza S M Elizabeth; Stephany H Donze; Sjoerd A A van den Berg; Laura C G de Graaff; Anita C S Hokken-Koelega
Journal:  J Clin Med       Date:  2022-02-26       Impact factor: 4.241

Review 8.  Utility of free IGF-I measurements.

Authors:  Jan Frystyk
Journal:  Pituitary       Date:  2007       Impact factor: 3.599

9.  Association analysis of insulin-like growth factor-1 axis parameters with survival and functional status in nonagenarians of the Leiden Longevity Study.

Authors:  Evie van der Spoel; Maarten P Rozing; Jeanine J Houwing-Duistermaat; P Eline Slagboom; Marian Beekman; Anton J M de Craen; Rudi G J Westendorp; Diana van Heemst
Journal:  Aging (Albany NY)       Date:  2015-11       Impact factor: 5.682

10.  Relationship between growth velocity and change of levels of insulin-like growth factor-1, insulin-like growth factor binding protein-3 and, IGFBP-3 promoter polymorphism during GnRH agonist treatment.

Authors:  Jun-Hong Park; Il-Tae Hwang; Seung Yang
Journal:  Ann Pediatr Endocrinol Metab       Date:  2020-07-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.